© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
Respiratory
FDA Guidance Provides Safety, Quality Standards for COVID-19 Vaccine Development
June 30, 2020
In a new guidance, the FDA provides recommendations for those developing COVID-19 vaccines to ensure safety and efficacy.
Part 2: A Conversation on Remdesivir Trial Updates
June 29, 2020
Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.
Children’s Cough Relief Products Recalled for Wrong Dosing Cups
June 23, 2020
The FDA warned that the dosing cups, which were missing some graduation markings, could cause an accidental overdose.
CDC Urges Routine Vaccinations Despite COVID-19 Pandemic
June 17, 2020
The CDC released an updated vaccination guidance on administering routine vaccinations amid the coronavirus disease 2019 (COVID-19) pandemic.
FDA Revokes EUA for Chloroquine and Hydroxychloroquine
June 15, 2020
Since the emergency use authorization was granted, new data on heart risks associated with hydroxychloroquine and chloroquine have been revealed.
Pharmacies Prepare For Possible Surge In Flu Vaccinations This Season
June 15, 2020
Pharmacies are preparing for what is expected to be a surge in flu vaccinations this year as Americans are putting a greater focus on staying healthy amid the coronavirus pandemic.
FDA OKs Antibiotic for Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
June 08, 2020
Officials with the FDA have approved imipenem, cilastatin, and relebactam (Recarbrio, Merck) for the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia.
Drug Interaction Concerns for Potential COVID-19 Treatments
May 22, 2020
A close look at their potential to interact with other medications is required to limit the risk of adverse outcomes for patients.
Investigational Drugs in the Pipeline for COVID-19
May 12, 2020
Investigators are evaluating a variety of medications for the novel coronavirus disease 2019 (COVID- 19), and the possible treatment landscape is rapidly evolving.
Hydroxychloroquine Shows No Benefit for COVID-19 in Observational Study
May 08, 2020
Hydroxychloroquine has been widely used for treatment of COVID-19, despite the lack of strong evidence supporting its efficacy.